| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Models |
From the Robert-Koch-Institute,* Berlin, Germany; the Department of Neurology, Georg-August-University, Göttingen, Germany; and the Department of Environmental Sciences, Eidgenossische Technische Hochschule Zürich, Swiss Federal Institute of Technology, Zürich, Switzerland
Abstract
Prion-induced chronic neurodegeneration has a substantial inflammatory component, and the activation of glia cells may play an important role in disease development and progression. However, the functional contribution of cytokines to the development of the gliosis in vivo was never systematically studied. We report here that the expression of interleukin-1ß (IL-1ß), IL-1ß-converting enzyme, and IL-1 receptor type 1 (IL-1RI) is up-regulated in a murine scrapie model. The scrapie-induced gliosis in IL-1RI–/– mice was characterized by an attenuated activation of astrocytes in the asymptomatic stage of the disease and a reduced expression of CXCR3 ligands. Furthermore, the accumulation of the misfolded isoform of the prion protein PrPSc was significantly delayed in the IL-1RI–/– mice. These observations indicate that IL-1 is a driver of the scrapie-associated astrocytosis and possibly the accompanying amyloid deposition. In addition, scrapie-infected IL-1RI-deficient (IL-1RI–/–) mice showed a delayed disease onset and significantly prolonged survival times suggesting that an anti-inflammatory therapeutical approach to suppress astrocyte activation and/or glial IL-1 expression may help to delay disease onset in established prion infections of the central nervous system.
This article has been cited by other articles:
 |
|
 |
|
  C.-H. Song, O. Honmou, N. Ohsawa, K. Nakamura, H. Hamada, H. Furuoka, R. Hasebe, and M. Horiuchi Effect of Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Mice Infected with Prions J. Virol., June 1, 2009; 83(11): 5918 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Riemer, J. Schultz, M. Burwinkel, A. Schwarz, S. W. F. Mok, S. Gultner, T. Bamme, S. Norley, F. van Landeghem, B. Lu, et al. Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3-/- Mice J. Virol., December 15, 2008; 82(24): 12464 - 12471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O'Shea, E. G. Maytham, J. M. Linehan, S. Brandner, J. Collinge, and S. E. Lloyd Investigation of Mcp1 as a Quantitative Trait Gene for Prion Disease Incubation Time in Mouse Genetics, September 1, 2008; 180(1): 559 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tamguney, K. Giles, D. V. Glidden, P. Lessard, H. Wille, P. Tremblay, D. F. Groth, F. Yehiely, C. Korth, R. C. Moore, et al. Genes contributing to prion pathogenesis J. Gen. Virol., July 1, 2008; 89(7): 1777 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Riemer, M. Burwinkel, A. Schwarz, S. Gultner, S. W. F. Mok, I. Heise, N. Holtkamp, and M. Baier Evaluation of drugs for treatment of prion infections of the central nervous system J. Gen. Virol., February 1, 2008; 89(2): 594 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Rambold, M. Miesbauer, D. Rapaport, T. Bartke, M. Baier, K. F. Winklhofer, and J. Tatzelt Association of Bcl-2 with Misfolded Prion Protein Is Linked to the Toxic Potential of Cytosolic PrP Mol. Biol. Cell, August 1, 2006; 17(8): 3356 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vet. Pathol., November 1, 2004; 41(6): 712 - 712. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
